Type 2 Diabetes Trial, Recruiting (NCT03156478)

Type 2 Diabetes Trial, Recruiting NCT03156478 Sponsor: University of Eastern Finland Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT03156478 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People between 18 and 70 years of age
People who score 12 or more on a Finnish diabetes risk questionnaire, or who have had diabetes during a previous pregnancy, or who have had repeated blood sugar readings that are higher than normal but not yet at diabetes level (confirm with trial site for exact values)
People who live in the Northern Savo, Päijät-Häme, or South Karelia hospital districts in Finland
People who have regular access to a computer, smartphone, or tablet with an internet connection
People who have their own mobile phone number
People with a sufficient level of Finnish language skills

Who may not be able to join:

People who have already been diagnosed with type 1 or type 2 diabetes
People who are currently pregnant or breastfeeding
People who currently have cancer, or who have finished cancer treatment within the last 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jussi Pihlajamäki, MD, PhD, University of Eastern Finland

Phone: +358 50 344 0187

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03156478

Sponsor: University of Eastern Finland

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: +358 50 344 0187

More information: https://clinicaltrials.gov/study/NCT03156478

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People between 18 and 70 years of age
People who score 12 or more on a Finnish diabetes risk questionnaire, or who have had diabetes during a previous pregnancy, or who have had repeated blood sugar readings that are higher than normal but not yet at diabetes level (confirm with trial site for exact values)
People who live in the Northern Savo, Päijät-Häme, or South Karelia hospital districts in Finland
People who have regular access to a computer, smartphone, or tablet with an internet connection
People who have their own mobile phone number
People with a sufficient level of Finnish language skills

Who may not be able to join:

People who have already been diagnosed with type 1 or type 2 diabetes
People who are currently pregnant or breastfeeding
People who currently have cancer, or who have finished cancer treatment within the last 6 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Eastern Finland

Registry

ClinicalTrials.gov

Start date

10 April 2017

Est. completion

1 December 2018

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Change in diet; Change in total physical activity level; Change in plasma glucose levels; Change in body weight

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov